BioPorto Diagnostics
Hellerup
About BioPorto Diagnostics
BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Their pioneering product portfolio includes assays for underserved disease states, such as NGAL for acute kidney injury. They sell their products in more than 80 countries through diverse sales channels and partners. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the Nasdaq Copenhagen stock exchange.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $23.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2025)
- Ticker: cph:BIOPOR
- Website: bioporto.com
- Phone: +45 45 29 00 00
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/bioporto-diagnostics-156703 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.